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Mannose 6-Phosphate Receptor Dependence
of Varicella Zoster Virus Infection In Vitro
and in the Epidermis during Varicella and Zoster
in adults (Seward and Wharton, 2000) assures that the
clinical problems of VZV will not soon disappear.
A paradox has long hampered VZV research. The virus
is highly infectious because the airborne virions that
emerge from cutaneous lesions readily transmit VZV.
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Summary The cell association of VZV has been attributed to the
diversion of newly assembled virions to late endosomes
Varicella zoster virus (VZV) is a highly infectious human where they are degraded prior to exocytosis (Gabel et
pathogen; nevertheless, infectious virions are not re- al., 1989; Gershon et al., 1994). Virions accumulate in
leased in vitro where infection is cell associated. Four late endosomes, and the virions released from cultured
VZV envelope glycoproteins contain mannose 6-phos- cells are distorted and different in morphology from the
phate (Man 6-P), and Man 6-P blocks infection of cells infectious virions found in fluid collected from cutaneous
by cell-free VZV. Expression of antisense cDNA or vesicles. Nucleocapsids assemble in the nuclei of in-
siRNA-like transcripts were used to generate five sta- fected cells (Figure 1A, 1), acquire an envelope from the
ble human cell lines deficient in cation-independent inner nuclear membrane as they bud into the perinuclear
mannose 6-phosphate receptors (MPRci). All 5 MPRci- cisterna (Figure 1A, 2 and 3), and fuse with the RER to
deficient lines resisted infection by cell-free, but not release nucleocapsids into the cytosol (Figure 1A, 4).
cell-associated, VZV, secreted lysosomal enzymes, Viral glycoproteins (gps) are synthesized in the RER and
and released infectious virions when infected by cell- are targeted to the trans-Golgi network (TGN) (Gershon
associated VZV. Intracellular MPRci thus appear to di- et al., 1994; Zhu et al., 1995c). Within the TGN, vacuoles
vert newly enveloped VZV to late endosomes, and form “envelopment” sacs with concave and convex
plasmalemmal MPRci are necessary for entry by cell- faces (Figure 1A, 5). Viral and cellular gps are separated
free VZV. Biopsies from VZV-infected human skin sup- in the envelopment sacs of the TGN so that viral gps sort
ported the idea that becauseMPRci expression is natu- to the concave face, while cellular proteins, including the
rally lost in maturing superficial epidermal cells, these large cation-independent mannose 6-phosphate recep-
cells do not divert VZV to endosomes and constitu- tor (MPRci), sort to the convex face. The concave face
tively secrete infectious VZV. becomes coated with tegument; envelopment sacs en-
circle nucleocapsids, and ultimately fuse to enclose
them with trapped tegument (Wang et al., 2001) (Figure
Introduction
1A, 6). The original concave face becomes the viral enve-
lope, while the MPRci-containing convex face becomes
Varicella zoster virus (VZV) is the causative agent of two a transport vesicle (Figure 1A, 7). The transport of newly
diseases, varicella (chickenpox) and zoster (shingles) enveloped VZV to late endosomes (Figure 1A, 8), which
(Weller, 1983, 1996). After an acute varicella infection is are on the itinerary of MPRcis, could be explained by
cleared, VZV establishes latency in ganglia from which the presence of MPRcis in the membrane of the vesicles
it can emerge later in life to give rise to a secondary that transport the virions.
infection, zoster. In contrast to varicella, which is dis- VZV is modified to interact with MPRcis. At least four
seminated, zoster, occurring in partially immune hosts, viral gps (gB, gE, gH, gI) contain N-linked complex oligo-
is usually limited to the dermatomes innervated by the saccharides with Man 6-P groups and thus are ligands
ganglia in which reactivation occurs. Zoster is a pressing for MPRcis (Gabel et al., 1989). An interaction between
medical problem because it may be followed by severe the Man 6-P groups of viral gps with MPRcis of the TGN
pathological pain, post-herpetic neuralgia, which is re- (Griffiths et al., 1988; Kornfeld, 1987) might be responsi-
sistant to therapy (Gilden et al., 2000). Although a vari- ble for the packaging of newly assembled VZV in MPRci-
cella vaccine is available (Arvin and Gershon, 1996), the containing transport vesicles, which are transported to
existence of a large pool of potentially infectious VZV late endosomes. MPRcis also traffic to plasmalemmae
where they mediate the retrieval of secreted lysosomal
enzymes by receptor-mediated endocytosis (Canfield*Correspondence: mdg4@columbia.edu
4 These authors contributed equally to this work. et al., 1991; Dahms et al., 1989; Johnson et al., 1990;
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VZV and infection by cell-free VZV are MPRci dependent.
These hypotheses have previously resisted analysis be-
cause available cell lines lacking MPRcis have been from
nonhuman species, and VZV grows well only in human
cells. We thus engineered five stable MPRci-deficient
human melanoma cell lines (MeWo) by expression of
antisense cDNA or siRNA-like transcripts. We now re-
port that all five lines resist infection by cell-free but not
cell-associated VZV; moreover, once infected, MPRci-
deficient cells secrete infectious VZV. These experi-
ments confirm the ideas that both the infection of naı¨ve
cells by cell-free VZV and the diversion of newly assem-
bled VZV to late endosomes within infected cells require
the participation of MPRcis. VZV infection (in varicella
and zoster) and the distribution of MPRcis in human
epidermis were also analyzed and found to be consis-
tent with the idea that VZV is not diverted to endosomes
in superficial epidermal cells, where infectious virions
emerge in vivo, because MPRcis are lost as epidermal
cells mature to form squames.
Results
MPRci-Deficient MeWo Cells Were Constructed
by Transfection with Antisense cDNA
MeWo cells can be infected with VZV (Harson and Grose,
1995; Mallory et al., 1997). Wild-type MeWo cells alsoFigure 1. Egress of VZV from Infected Cells; Expression of MPRci
express MPRcis (Figure 1B) and concentrate them in thein the TGN Is Decreased in Transfected Cells Expressing MPRci
cDNA in the Antisense Configuration (MPR-KD cells) TGN (Figure 1D). To generate MPRci-deficient cell lines
by stably expressing cDNA encoding the MPRci in the(A) Diagram showing the proposed pathway of VZV envelopment
and egress. (1) Nucleocapsids assemble in the nucleus; (2) acquire antisense configuration, a modified retroviral vector was
a temporary envelope from the inner nuclear membrane while (3) constructed that carried 3 kb of the antisense cDNA and
budding into the perinuclear cisterna; (4) the temporary envelope a puromycin resistance cassette. The resulting retroviral
fuses with the RER as nucleocapsids are translocated to the cytosol;
particles were packaged and used to infect MeWo cells,(5–6) the nucleocapsids and tegument are finally enveloped by modi-
which were selected and maintained in the presence offied cisternae in the TGN; (7) the inner tegument-lined membrane
puromycin. Expression of MPRcis was found by Westernof the TGN enveloping cisterna becomes the viral envelope, and
the outer (MPR-containing) membrane becomes a transport vesicle; analysis (Figure 1B) and immunocytochemistry (Figures
(8) the vesicles that contain newly enveloped VZV transfer virions 1D and 1E) to be downregulated in the vector-infected
to late endosomes where VZV is degraded in the acidic internal cells (MPRci-KD cells). The cellular content of a represen-
milieu; (9) degraded virions are released to the external medium (10)
tative lysosomal enzyme, cathepsin D, was found, bothby exocytosis.
by Western analyses (Figure 1C) and immunocytochem-(B) Western analysis (30 g protein) reveals that MPRci expression
istry (Figures 1F and 1G) to be reduced in MPRci-KDis downregulated in MPRci-KD cells.
(C) Western analysis (30 g protein) reveals that cell-associated cells, suggesting that the diversion of lysosomal en-
cathepsin D is reduced in MPRci-KD cells. zymes from the secretory to the endosomal pathway in
(D) MPRci immunoreactivity is concentrated in the TGN region (arrow) MPRci-KD cells is defective. Such a defect would be
of wild-type MeWo cells.
expected to cause lysosomal enzymes to be constitu-(E) Concentration of MPRci in the TGN region of MPR-KD cells is
tively secreted. This expectation was confirmed; the ac-reduced (compare with [D]).
tivity of another representative lysosomal enzyme, acid(F) Cathepsin D immunoreactivity is present in lysosomes of wild-
type MeWo cells. phosphatase, released to the ambient media from cul-
(G) Concentration of cathepsin D in lysosomes of MPR-KD cells is tured MPRci-KD cells was greater than that of parental
reduced (compare with [F]). MeWo cells. The ratio of acid phosphatase activity in
The markers: (D)–(G)  20 m.
the culture medium to that in wild-type cells was 0.82
0.13, but in the MPRci-KD cells the ratio was 1.45 0.07
(p  0.02).Kornfeld, 1987). Exogenous Man 6-P, which competi-
tively antagonizes the uptake of lysosomal enzymes,
also inhibits the infection of target cells by cell-free (but MPRci-Deficient Cells Are Resistant
to Infection by Cell-Free VZVnot cell-associated) VZV (Gabel et al., 1989; Zhu et al.,
1995a) and the uptake of VZV gps (Wang et al., 2000). Cell-free VZV (Ellen strain) was obtained from infected
human embryonic lung fibroblasts (HELF), which wereIt is thus possible that MPRcis function both in the infec-
tion of target cells by free virions and in the diversion sonicated to release infectious virions. Cell-free virus
was clarified by centrifugation and applied to controlof newly assembled VZV to late endosomes.
The current study was carried out to test the hypothe- MeWo and MPRci-KD cells (in the absence of puromy-
cin). VZV-infected cells were identified by the immuno-ses that the intracellular navigation of newly assembled
Man 6-P Receptors in VZV Entry and Egress
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Figure 2. MPRci-KD Cells Resist Infection by
Cell-Free but Not Cell-Associated VZV.
(A) Wild-type MeWo cells are infected after
exposure to cell-free VZV and express gE
(green fluorescence).
(B) MPRci-KD cells exposed to cell-free VZV
do not express gE.
(C) Quantitation of plaques in wild-type
MeWo cells, MPRci-KD cells, and after rever-
sion to the wild-type phenotype (recovery).
Data are normalized to the mean plaque
count observed when wild-type MeWo are
inoculated with cell-free VZV. Differences be-
tween each type of cell are significant (p 
0.001). Error bars are  standard error of
the mean.
(D) Wild-type MeWo cells exposed to cell-
associated VZV are infected and express gB
(green fluorescence) and ORF62p (red fluo-
rescence). Note formation of syncytia.
(E) MPRci-KD cells exposed to cell-associ-
ated VZV are also infected and also express
gB (green fluorescence) and ORF62p (red
fluorescence).
(F) Wild-type MeWo cells infected with VZV
express gB (green fluorescence) in the cyto-
plasm and ORF62p (red fluorescence) in the
nucleus. Infected cells form syncytia.
(G) MPRci-KD cells exposed to cell-associ-
ated VZV express gE (green fluorescence)
and ORF29p (red fluorescence). Infected cells
form syncytia.
The markers: (A) and (B)  20 m; (D)–(G) 
50 m.
cytochemical detection of viral antigens (gE, gB, cells by VZV; moreover, VZV gps are not expressed
during latency (Kinchington et al., 2000; Lungu et al.,ORF62p, ORF29p). While parental MeWo cells were
readily infected (18.75  2.18 plaques/culture; Figures 1995, 1998). Infections were thus lytic and not latent.
2A and 2C), MPRci-KD cells were highly resistant to infec-
tion by cell-free VZV (2.5  1.0 plaques/culture; p  MPRci-Deficient Cells Secrete Infectious VZV
To determine whether MPRci-KD secrete more infectious0.001 versus wild-type; Figures 2B and 2C); moreover,
when MPRci-KD cells were allowed to revert to the wild- VZV than parental MeWo cells, each was infected with
cell-associated VZV (in HELF) as described above. Me-type phenotype by maintenance for seven successive
generations in the absence of puromycin, the cells re- dia were collected 3 days later, centrifuged at 2000 rpm
to remove cells, and applied to recipient HELF mono-covered their susceptibility to infection by cell-free VZV
(38.5 2.5 plaques/culture; p 0.001 versus MPRci-KD layers. The monolayers were examined for plaques at
daily intervals, fixed after 1 week, and processed for thecells; Figure 2C). Infection of wild-type MeWo cells by
cell-free VZV, like that of HELF (Gabel et al., 1989; Zhu demonstration of VZV antigens. Media in which infected
MeWo cells were cultured contained little or no infec-et al., 1995b), was inhibited by the addition of exogenous
Man 6-P (data not shown). Because the infection of cells tious VZV (Figures 3A and 3B). In contrast, infectious
VZV was always found in media in which MPRci-KD cellsby cell-associated VZV, which involves the fusion of
infected cells with their neighbors, is not affected by were cultured (Figures 3C and 3D). MPRci-KD cells thus
secrete more infectious VZV than do parental MeWoMan 6-P and thus is MPRci independent (Gabel et al.,
1989), the ability of cell-associated VZV to infect MPRci- cells.
To verify that the release by MPRci-KD cells of infec-KD cells was evaluated. Infected HELF cells were ap-
plied to cultures of MeWo and MPRci-KD cells; both were tious VZV to media and the loss of susceptibility of
MPRci-KD cells to infection by cell-free VZV was due toreadily infected by cell-associated VZV (Figures 2D–2G)
and fused to form syncytia (Figures 2F and 2G). The MPRci knockdown, MPRci-deficient cells were generated
by independent means and compared to MPRci-KD cells.immunoreactivities of ORF62p (Figure 2F) and ORF29p
(Figure 2G) were intranuclear, while those of gE (Figure A mammalian expression vector (pSUPER RNAi System;
OligoEngine, Seattle, Washington) was used to direct2G) and gB (Figure 2F) were cytoplasmic. These obser-
vations support the ideas that the infection of target intracellular synthesis of siRNA-like transcripts that tar-
geted four different regions of the MPRci sequence. Tran-cells by cell-free VZV is MPRci-dependent while infection
of target cells by cell-associated VZV (fusion) is MPRci- scripts encoding MPRci were found by real-time RT-PCR
to be decreased in the resulting cell lines (48.5% 8.0%independent. ORFs 62p and 29p are cytoplasmic during
latent infection but intranuclear during lytic infection of of control; p  0.003), which also contained reduced
Cell
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Figure 3. Infected MPRci-KD Cells (and Cells
Expressing siRNA Targeting the MPRci) Re-
lease Infectious VZV, but Wild-Type MeWo
Cells Do Not
(A and B) Media from wild-type MeWo cells
infected with cell-associated VZV was ap-
plied to a recipient monolayer of HELF cells.
The HELF cells do not express gE (A) or
ORF29p (B).
(C and D) Media from MPRci-KD cells infected
with cell-associated VZV was applied to a re-
cipient monolayer of HELF cells. The HELF
cells express gE ([C], green fluorescence) and
ORF29p ([D], red fluorescence).
(E) MPR content is comparably reduced in
MPRci-KD cells and in four cell lines express-
ing siRNA-targeting MPRci.
(F) Initial infection by cell-free VZV of MPRci-
KD cells and cell lines expressing siRNA-tar-
geting MPRci is deficient (culture volume 
3.0 ml).
(G) After infection with cell-associated VZV,
MPRci-KD cells and cell lines expressing
siRNA-targeting MPRci release infectious VZV
to the ambient media (2.0 ml of supernatant
transferred to recipient HELF cells).
All error bars are  standard error of the
mean.
MPRci immunoreactivity in Western blots (Figure 3E). observed in the cytosol, indicating virions became deen-
veloped by fusing with the membrane of the endoplas-The mean MPRci immunoreactivity (normalized to that
of vinculin) of MPRci-KD and the four siRNA-synthesizing mic reticulum as they do in control cells (Gershon et al.,
1994) and envelopment sacs were also seen in the TGNcell lines was 44.3%  3.4% of control (p  0.0001),
and each contained significantly less MPRci immunore- (Figure 4E). The most striking difference between VZV-
infected wild-type MeWo cells and MPRci-deficient cellsactivity than control (p 0.001). Like MPRci-KD cells, the
MPRci-deficient siRNA-synthesizing cell lines resisted was the presence in the MPRci-deficient cells of small
post-Golgi vesicles containing individual virions (Figuresinfection with cell-free VZV (Figure 3F; 27.8%  9% of
control; p  0.002) and, when infected by cell-associ- 4D–4F). In MPRci-deficient cells, therefore, the diversion
of newly enveloped VZV to late endosomes either doesated VZV, released infectious VZV to the ambient media
(Figure 3G; 1090.0%  265.3% of control; p  0.02). not occur or occurs at a frequency too low to detect.
Instead, individual virions are packaged individually in
small vesicles, an appearance that is consistent withDiversion of Newly Enveloped VZV to Endosomes
constitutive secretion.Does Not Occur in MPRci-Deficient Cells
Electron microscopy was used to compare the traffick-
ing of VZV in wild-type MeWo and MPRci-deficient cells. The Intracellular Pathway of VZV Maturation
in Superficial Epidermal Cells of InfectedIn parental MeWo cells, enveloped virions were found
to accumulate in large cytoplasmic vacuoles (Figure 4A). Patients Resembles that of MPRci-KD Cells
Infectious VZV sheds from cutaneous lesions both inThese vacuoles have been described previously (Harson
and Grose, 1995) and are also seen in infected HELF varicella and zoster (Gershon and Silverstein, 2002). This
phenomenon implies that the fate of VZV processed bycells (Cook and Stevens, 1968, 1970; Gershon et al.,
1973), in which they have been demonstrated to be late infected epidermal cells must be different from that of
VZV processed by infected cells in vitro. To analyze theendosomes (Gabel et al., 1989; Gershon et al., 1994). The
virions within late endosomes and extracellular virions pathway of viral maturation in epidermal cells, biopsies
of infected cutaneous vesicles and samples of vesicleappear pleomorphic and degraded. Similar vacuoles
were not observed in VZV-infected MPRci-KD or siRNA- fluid were obtained from patients during varicella and
zoster and analyzed by immunocytochemistry and elec-synthesizing cells. In these cells, the early steps in the
pathway of viral maturation were found to be similar to tron microscopy. In affected regions, both in zoster (Fig-
ures 5A, 5C, and 5D) and varicella (Figure 5B), the cellsthose previously described. Nucleocapsids assembled
in the nuclei of infected MPRci-deficient cells, often in surrounding epidermal vesicles were found to be out-
lined by gI (Figures 5A and 5C) and gE immunoreactivi-regular arrays (Figure 4B). Enveloped virions were found
to exit from the nucleus by budding into the perinuclear ties (Figure 5B). The infected cells that surrounded le-
sions were separated from the epidermal surface by acisterna (Figure 4C). Unenveloped nucleocapsids were
Man 6-P Receptors in VZV Entry and Egress
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Figure 4. The Intracellular Pathway of Viral Maturation Differs in Parental MeWo and MPRci-Deficient Cells
(A) Wild-type MeWo cells. Pleomorphic virions (arrows) accumulate in large cytoplasmic vacuoles (v). There are multiple viral particles in each
cytoplasmic vacuole.
(B–D) MPRci-KD cells.
(B) VZV nucleocapsids assemble in regular arrays in the nucleus (nuc).
(C) Virions acquire a primary envelope from the inner nuclear membrane while budding into the perinuclear cisterna (arrow).
(D) Enveloped VZV is found in small transport vesicles (arrows) within the cytoplasm of an infected cell. The virions are well formed, and only
one virion appears in each transport vesicle (compare with [A]).
(E and F) Cells expressing siRNA-targeting MPRci.
(E) TGN region. One nucleocapsid is acquiring a final envelope, and another has been newly enveloped and lies within a transport vesicle.
(F) As in MPRci-KD cells, individual virions are located in transport vesicles (arrows).
The markers: (A) and (B)  500 nm; (D)–(F)  250 nm.
thin layer of uninfected cells (Figure 5A, arrows). Intracel- (Figures 5C and 5D) than in the more flattened luminal
cells (Figure 5A). gI immunoreactivity was predominantlylular immunofluorescence was more apparent in cells
located 5–7 cell diameters removed from the cavities found at cell surfaces but was also detectable in Golgi
Cell
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Figure 5. The Immunoreactivities of gE and gI Are Expressed by Cells in the Cutaneous Vesicular Lesions of Patients with Varicella or Zoster;
MPRcis Are Expressed by Cells of the Basal but Not Superficial Epidermis
(A) Zoster, gI immunoreactivity (red fluorescence). The cavity of the lesion is not immunoreactive; however; gI-immunoreactive cells surround
the cavity. There is a layer of uninfected cells between the surface of the epidermis (outlined by arrows) and the infected cells lining the cavity.
gI immunoreactivity is strikingly marginal, outlining the infected cells.
(B) Varicella, gE immunoreactivity (green fluorescence). As with gI, gE immunoreactivity outlines cell boundaries and obliterates the intercellular
space. Intercellular gE immunoreactivity appears to be punctate.
(C) Zoster, gI immunoreactivity (red fluorescence). Intracellular gI immunoreactivity appears in a subset of cells at some distance from the cavity.
(D) Zoster, gE immunoreactivity (red fluorescence). Intracellular gE immunoreactivity is concentrated in the Golgi region (arrow; presumably
the TGN) of infected cells distant from the vesicular lumen.
(E–G) Normal human skin doubly stained to demonstrate simultaneously MPRci immunoreactivity (green fluorescence) and, for orientation,
DNA (blue fluorescence). The overlaid images are shown in (G). Der  Dermis. Note that MPRci immunoreactivity is prominent in basal cells
but is lost from the maturing superficial layers of cells.
(H, inset on [G]) Normal human skin stained to visualize nerve fibers by demonstrating the immunoreactivity of the neuronal marker, 3-tubulin.
Note the varicose intraepidermal nerve fiber extending into the superficial epidermis below the cornified surface layer.
The marker: (E)–(H)  20 m.
regions (Figure 5C). In cells near epidermal vesicles, gE neuronal marker, 3-tubulin (Figure 5H). MPRci immuno-
reactivity was prominent in basal epidermal cells (Figureimmunoreactivity was also mainly plasmalemmal (Figure
5B); however, in the basal epidermis (Figure 5D), as 5E) but was lost in superficial cells that were maturing
to give rise to the squames of the stratum corneum.in vitro (Zhu et al., 1995c), gE immunoreactivity was
concentrated in the region of the TGN. Intraepidermal nerve endings extended into the MPRci-
deficient superficial layers of the epidermis where VZVTo relate the epidermal distribution of VZV to MPRcis,
it is necessary to know the distribution of MPRcis in the immunoreactivity is maximally concentrated during vari-
cella and zoster.layers of the human epidermis. MPRci immunoreactivity
was therefore studied in human skin biopsies (Figures Electron microscopic examination of fluid aspirated
from the epidermal vesicles of patients with varicella5E–5G). DNA was simultaneously stained to reveal the
layering of the epidermis (Figures 5F and 5G). Intraepi- revealed it to be packed with viral particles (Figure 6A).
Most of these virions exhibited a strikingly ordered mor-dermal nerves were also located by immunostaining the
Man 6-P Receptors in VZV Entry and Egress
921
Figure 6. The Intracellular Pathway of VZV Maturation Is Different in Superficial and Basal Cells of the Epidermis
Aspirates of vesicular cutaneous lesions from patients with varicella and biopsies of patients with varicella and zoster were obtained.
(A) Vesicular fluid aspirated from a patient with varicella. Note the abundance of intact virions and the excellent preservation of the structure
of all components of the virions.
(B) Superficial epidermis near a vesicular cutaneous lesion. A deenveloped nucleocapsid is half enclosed by an envelopment sac of the TGN.
The virion was fixed while acquiring its final envelope.
(C) Superficial epidermis near a vesicular cutaneous lesion. Several stages of post-Golgi viral maturation can be distinguished in the field,
including the reenvelopment of virions in the TGN and the transport of individual enveloped virions in cytoplasmic vesicles (arrows).
(D) Virions are found in the extracellular space between adjacent epidermal cells. Note the excellent preservation of the structure of several
of the extracellular virions (arrows).
(E) At higher magnification an intact extracellular virion abuts an intercellular bridge near a desmosome. Note the excellent preservation of
the structure of all components of the virion.
(F) VZV-infected basal cell of the epidermis. Virions have accumulated in large intracellular vacuoles (v). The structure of the virions within
these vacuoles is pleomorphic, suggesting that the particles have been degraded. Markers  100 nm.
Cell
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phology. Viral envelopes were intact and bordered on Parental MeWo cells were readily infected by cell-free
VZV and, consistent with a necessary role for MPRcis,their internal face by a uniform osmiophilic layer of tegu-
infection by cell-free VZV was antagonized by Man 6-P.ment. The nucleocapsids and DNA cores were similarly
Infection of cells by cell-associated VZV, which involvesregular and intact. Stages of formation of the mature
cell fusion (Weller, 1983), is not antagonized by Man 6-Pvirions found in vesicle fluid were readily seen in infected
and thus is MPRci independent. Fusion depends on gps,cells of the superficial epidermis of biopsies obtained
including gE, gB, gH, and gL (Duus and Grose, 1996;both in varicella and zoster (Figures 6B and 6C). The
Maresova et al., 2001). In contrast to the parental cellappearance of pre-Golgi forms of maturing virions was
line, all of the MPRci-deficient cells were resistant toidentical to those described previously in VZV-infected
infection with cell-free VZV, although they could easilytissue culture cells (Gershon et al., 1994). In particular,
be infected by cell-associated VZV. These observationsthe envelopment sacs, which characterize the final en-
suggest that the mechanism by which virions infectvelopment of VZV in the TGN, were abundant (Figures
cells, but not the ability of infected cells to fuse with their6B and 6C, compare with Figure 4E). The appearance
neighbors, is compromised by downregulating MPRci.of post-Golgi forms of maturing virions, however, resem-
Because MPRci-deficient cells support VZV infection, thebled those in MPRci-deficient cells, rather than those in
downregulation of MPRcis does not affect the growth ofwild-type MeWo or HELF. In the superficial epidermis,
the virus; moreover, when selective pressure is removedenveloped virions were found individually in small vesi-
and MPRci-KD cells revert to the parental phenotype,cles (Figure 6C, arrows). There was no concentration of
they can again be infected by cell-free VZV. The MPRci-virions in vacuoles, suggesting that virions were not
dependence of VZV, therefore, is restricted to infectionrouted to late endosomes. The individual enclosure of
by free virions.enveloped virions in small vesicles (Figure 6C) is thus
Viral infection of target cells requires adhesion of viri-vastly different from the concentration of dysmorphic
ons to the plasma membrane, entry, and the subsequentvirions in late endosomal vacuoles of infected wild-type
ability of the virus to replicate and assemble progeny.MeWo cells (Figure 4A); moreover, the morphology of
The initial adherence of VZV to the plasma membranethe virions in transport vesicles of infected superficial
of target cells depends on heparan sulfate proteoglycan,epidermal cells is intact and similar to that of virions
rather than MPRcis (Zhu et al., 1995a). The abilities offound in the fluid withdrawn from cutaneous vesicular
VZV to replicate in target cells and assemble progenylesions (Figure 6A). VZV trafficking in superficial epider-
must also be independent of MPRcis because they occurmal cells is thus similar to that of VZV-infected MPRci-
in MPRci-deficient cells that have been infected by cell-deficient cells (Figures 4D–4F). These observations are
associated VZV. The role of the MPRci in the infectionconsistent with the idea that newly enveloped VZV is
of target cells, therefore, appears to be in the processnot diverted to late endosomes in the MPRci-deficient
of viral entry. This conclusion is also supported by thecells of the superficial epidermis. Perhaps as a result, the
prior observation that exogenous Man 6-P interferesVZV-infected superficial epidermal cells secrete intact
with infection of target cells by cell-free VZV only if it isVZV, which are found in the intercellular spaces between
added within one hour of inoculation (Zhu et al., 1995a).cells of the epidermis (Figures 6D and 6E).
Once infected by cell-associated VZV, MPRci-deficientThe ultrastructural appearance of basal cells of in-
cells secrete infectious VZV. The medium in which in-fected regions of the epidermis differed from that of
fected MPRci-deficient cells are cultured, therefore,the superficial cells. Large vacuoles containing many
passes infection to monolayers of HELF cells. MPRci-pleomorphic virions (Figure 6F) were observed in basal
deficient cells are thus much less able than parentalcells. Infected cells of basal epidermis, like wild-type
MeWo cells to inactivate VZV prior to its release. Secre-MeWo cells (compare Figure 6F to Figure 4A), thus ap-
tion of infectious virions, therefore, like susceptibility topear to divert VZV to late endosomes. Diversion of VZV to
infection by cell-free VZV is MPRci dependent. Given
late endosomes thus occurs in the layer of the epidermis
that newly enveloped VZV traffics with MPRci from the
that contains MPRci immunoreactivity but does not oc-
TGN of infected cells to late endosomes (Gershon et al.,
cur where MPRci is deficient (see Figures 5E–5G). 1994; Zhu et al., 1995b), these data suggest that the
MPRci plays a necessary role in the diversion of VZV to
Discussion late endosomes, where virions are inactivated prior to
exocytosis. In the absence of this diversion, VZV, like
We tested hypotheses that both the diversion of newly lysosomal enzymes (Kornfeld, 1987), is constitutively
assembled VZV to late endosomes and the infection of secreted following its envelopment in the TGN. Because
target cells by cell-free VZV are MPRci dependent. MPRci- the constitutively secreted VZV thus bypasses the acidic
deficient human cell lines were generated from parental milieu of late endosomes (Gershon et al., 1994; Zhu et
MeWo cells by stable transfection with cDNA encoding al., 1995b), it is infectious.
the MPRci in the antisense configuration (MPRci-KD) and Prior evidence in support of the hypothesis that newly
by inducing the synthesis of siRNA targeting MPRci. enveloped VZV is diverted to late endosomes has in-
Downregulation of MPRci in the resulting lines was veri- cluded the accumulation of virions within these organ-
fied by Western blotting and by immunocytochemistry. elles (Gershon et al., 1994) and the dysmorphology of
The ability of the MPRci-deficient cells to concentrate virions found either within them or extracellularly. MPRcis
lysosomal enzymes in lysosomes was compromised, were demonstrated by immunoelectron microscopy
leading to a decrease in intracellular cathepsin D and within the membranes of the convex face of the envelop-
increased secretion of acid phosphatase; therefore, ment sacs of the TGN, where final assembly of virions
occurs and in the membranes of the later post-Golgidownregulation of MPRci was functionally significant.
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vacuoles that contain enveloped virions (Gershon et al., assembled virions are inactivated prior to their release
from infected cells seems counterintuitive. Although the1994). These data, however, did not establish whether
the MPRcis in the membranes of the TGN actually divert affinity of the Man 6-P-containing viral gps for MPRcis
might be advantageous in providing VZV with a cellvirions to vesicles that traffic to late endosomes or
whether virions are independently sorted to the endoso- surface receptor that it utilizes to enter target cells, the
same affinity would seem to ensure the death of newlymal pathway, which is marked by the cosorted MPRci.
In fact, the binding of viral gps to MPRcis, which are enveloped virions before they can be released to find
new target cells to infect. In fact, however, the diversionnormally concentrated in TGN membranes, might con-
ceivably cause the receptors to follow the itinerary of of VZV to late endosomes can be viewed as a mecha-
nism that benefits the virus because it restricts thevesicles that contain virions. The current observation
that inactivation of VZV during egress from five lines spread of infection within a host to the slow process of
cell-to-cell contact. Infected hosts are thus not over-of MPRci-deficient cells is impaired suggests that the
MPRcis participate in the sorting of virions. This sugges- whelmed by the dissemination of a flood of virions within
the circulation before an effective immune response cantion is further supported by the failure of enveloped
VZV to accumulate in late endosomes in MPRci-deficient be mounted. Instead, infection spreads slowly, enabling
adaptive host responses to be marshaled, so that thecells. The appearance instead of single virions in small
vesicles suggests that when MPRcis are deficient, enve- host survives the infection, a characteristic that distin-
guishes successful parasites. By the time intact virionsloped VZV enters the secretory pathway by default, as
the lysosomal enzymes cathepsin D and acid phospha- emerge in the skin, two weeks of incubation have oc-
curred (Grose, 1981), and the adaptive immune responsetase do in the same cells. The small vesicles containing
individual virions are probably secretory vesicles in the is ready (Arvin et al., 1986; Gershon et al., 1999) to limit
the damage that VZV might otherwise cause.constitutive pathway carrying infectious virions. Inter-
estingly, gD of the envelope of herpes simplex virus Assuring host survival is necessary but not sufficient
for successful parasitism. Also necessary is for VZV to(HSV) is also 6-manosylated (Brunetti et al., 1994); never-
theless, although newly assembled HSV accumulates in find a safe site(s) where infectious particles can be pro-
duced to spread infection to new hosts and gain accessendosomes, and viral entry is antagonized by competi-
tion at MPRcis; intracellular transport of HSV and viral to cells where immune surveillance can be evaded while
VZV remains in its host. We postulate that the skin isentry involve MPRci-independent as well as MPRci-
dependent mechanisms (Brunetti et al., 1995, 1998). Re- the site where these latter objectives are realized for
VZV. During varicella, infection is spread to the skin asceptors thus appear to be available to HSV that are not
utilized by VZV. the result of a viremia (Grose, 1981) in which VZV is
carried through the blood within infected lymphyocytesThe skin was examined because it is the major source
of infectious VZV in patients with varicella or zoster (Koropchak et al., 1989; Moffat et al., 1995; Zerboni et
al., 2000). Presumably these lymphocytes infect cells of(Tsolia et al., 1990; Weller, 1983). The ultrastructure of
infected basal cells, both in patients with varicella and the basal epidermis by cell-to-cell contact. We postulate
that infection then spreads to the superficial epidermalin those with zoster, was consistent with a pathway of
viral egress analogous to that seen in vitro in wild-type cells that specifically secrete infectious viral particles.
These free virions concentrate in the intraepidermal ves-MeWo cells (Harson and Grose, 1995; Jones and Grose,
1988) and HELF (Gershon et al., 1994). The stages identi- icles that characterize varicella, and the morphology of
virions sampled in fluid drawn from these vesicles orfied as those of nucleocapsid assembly, budding from
the nucleus into the perinuclear cisterna, and final envel- within the extracellular space is thus intact and not
dysmorphic, like that of virions in late endosomes oropment in the TGN were essentially identical. Most sig-
nificantly, enveloped virions accumulated in large cyto- secreted by wild-type MeWo cells. The intact virions
that accumulate in the epidermis can aerosolize withplasmic vacuoles, and the appearance of the virions
within these vacuoles was dysmorphic. These observa- the desquamation of the stratum corneum. Air laden
with infectious particles can then be inhaled by passingtions suggest that the pathway of viral maturation and
egress in basal cells of the epidermis resembles that of individuals who, if they are not already immune to VZV,
become new hosts for VZV. The epidermis is also inner-cultured cells and leads to the inactivation of VZV prior
to its secretion. In contrast, in infected cells in superficial vated by sensory nerves (Figure 5H), which lose their
sheaths as they pass through the basement membrane.layers of the epidermis, VZV did not accumulate in large
vacuoles. Instead, the virions in superficial epidermal Infectious virions thus come into contact with these na-
ked intraepidermal nerves, which we propose are in-cells were packaged individually in small vesicles, as in
MPRci-deficient cells in vitro. These observations sug- fected by an MPRci-dependent mechanism. Subsequent
retrograde transport then delivers VZV to the sensorygest that VZV is diverted by MPRcis to late endosomes
in infected cells of the basal epidermis, which contain ganglia in which it establishes latency, enabling VZV to
persist indefinitely despite the immunity of its hostMPRcis, but is not so diverted in the MPRci-deficient
superficial cells that are infected while they are maturing (Hope-Simpson, 1965; Silverstein and Straus, 2000).
This proposal is consistent with data obtained from aninto squames. During the process of maturation, kera-
tinocytes naturally lose the MPRci-mediated endosomal/ in vitro model of VZV infection of neurons in which we
find that latent infection is established when cell-freelysosomal pathway, although they retain the constitutive
pathway and secrete a waterproofing ceramide before virions infect nerves by a MPRci-dependent mechanism,
while lytic infection is induced when infected cells fusedying and becoming squames (Wertz, 2000).
That a highly successful parasite, such as VZV, could with neurons (Chen et al., 2003). Skin infection as a
result of the reactivation of VZV during zoster would behave evolved with a mechanism that assures that newly
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as those in higher layers of the epidermis that were not in contactpresumed to be identical to that during varicella, except
with the basement membrane. Cultured cells were prepared similarlythat VZV would be delivered to the epidermis by antero-
for immunocytochemical examination except that fixation was onlygrade transport in the same nerve fibers used previously
for 1 hr. Reagents used included monoclonal (ViroStat, Portland,
for the establishment of latency. The preexistence of Maine) and polyclonal (Wang et al., 2001) primary antibodies to gE,
protective immunity during zoster would confine the in- gI, ORF29p, and ORF62p, MPRci (Bhavsar et al., 1994), 3-tubulin
(Chemicon International, Inc.), cathepsin D (Lipshaw), and appro-fection to the skin of the dermatomes in which infection
priate affinity purified secondary antibodies labeled with fluoro-occurs (Hardy et al., 1991; Hope-Simpson, 1965). Again,
phores of contrasting colors (Jackson Laboratories; Molecularinfection of basal cells would lead to the inactivation of
Probes). Primary antibodies were omitted for controls.VZV by MPRci-mediated diversion to late endosomes,
while infection of superficial epidermal cells would lead
Measurement of MPRci Expression
instead to the secretion of infectious virions. Desquama- mRNA-encoding MPRci was measured by using real-time RT-PCR
tion of the stratum corneum and consequent aerosoliza- (Li et al., 2004) and protein by immunoblotting. For immunoblotting,
tion of intact VZV would enable VZV to spread from an the lysis buffer contained 10 mM Tris (pH 7.4), 1% Triton X-100,
0.5% Nonidet P40, 150 mM NaCl, 20 mM NaF, 0.2 mM sodiumindividual with zoster to new hosts, thereby preserving
orthovanadate, 1 mM EDTA, 0.2 mM phenylmethylsulfonyl fluoride,a reservoir from which VZV continually emerges to cause
and an additional cocktail of phosphatase and protease inhibitors.epidemics when a new pool of susceptibles develops.
Proteins (30 g) in the supernatant were denatured in Laemmli sam-
ple buffer (Laemmli, 1970), separated by 5% or 10% polyacrylamide
gel electrophoresis (Nu-PAGE gel; Invitrogen, Carlsbad, California),
Experimental Procedures
and transferred to a 0.2 m nitrocellulose membrane (Schleicher &
Schuell). Blots were blocked, exposed to affinity-purified polyclonal
Cells and Infection
antibodies to MPRci (Stuart Kornfeld, Washington University, St. Louis,
A low-passage VZV isolate (Jones) was propagated in human mela-
Missouri) and mouse antibodies to vinculin (Sigma), and secondary
noma (MeWo; Dr. Charles Grose, Iowa University) or human embry-
antibodies (1:5000, Pierce) were visualized by chemiluminescence
onic lung fibroblasts (HELF) cells (American Type Culture Collection,
(Super ECL, Pierce), scanned, and quantified densitometrically (Ko-
Manassas, Virginia) as previously described (Gershon et al., 1994).
dak digital science ID software). The measured immunoreactivity of
HELF were also used as recipients to assay the infectivity of media
MPRci in each sample was normalized to that of vinculin on the
in which infected cells were grown. Cell-free VZV was prepared from
same blot.
infected HELF by sonication (Schmidt and Lennette, 1976).
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